Last update 01 Nov 2024
Supriya Lifescience Ltd.

Supriya Lifescience Ltd.

Public Company|
1987|
India
|
500-1,000
| BOM: 543434|
www.supriyalifescience.com

Overview

Tags

Otorhinolaryngologic Diseases
Immune System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
H1 receptor(Histamine H1 receptor)1

Related

1
Drugs associated with Supriya Lifescience Ltd.
Brompheniramine Maleate
Target
H1 receptor
Mechanism
H1 receptor antagonists
Active Org.
Supriya Lifescience Ltd.Supriya Lifescience Ltd.
Originator Org.
Wyeth AB
Active Indication
Rhinitis, Allergic
Inactive Indication
Common Cold
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date23 Aug 1957
1
Clinical Trials associated with Supriya Lifescience Ltd.
CTRI/2024/02/062836 / Not yet recruitingPhase 1/2
To study and compare the effect of preoperative nebulized Magnesium sulphate versus Lignocaine in reducing the incidence of post-operative pharyngo-laryngeal complications in patients undergoing surgery under general anaesthesia with cuffed Endotracheal tube - A prospective triple blind randomised control trial - NIL
100 Clinical Results associated with Supriya Lifescience Ltd.
Login to view more data
0 Patents (Medical) associated with Supriya Lifescience Ltd.
Login to view more data
100 Deals associated with Supriya Lifescience Ltd.
Login to view more data
100 Translational Medicine associated with Supriya Lifescience Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Brompheniramine Maleate
 ( H1 receptor )		Rhinitis, Allergic
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free